University of Grenoble   Report issue

Academic/Hospital Phase 1 Phase 2 Phase 3 Phase 4
Founded: Grenoble France (1339)

Organization Overview

First Clinical Trial
1987
NCT00849082
First Marketed Drug
None
First NDA Approval
None
Last Known Activity
2022

Timeline

NOW
  • Now

Alternative names

AGDUC - Grenoble | Cardiac Surgery Department - University Hospital of Grenoble, | Centre d'Investigation Clinique de Grenoble CIC1406 | CHU de Grenoble Alpes | CHU de Grenoble - Hopital de la Tronche | CHU DE GRENOBLE - LA TRONCHE | CHU Grenoble | chu gRENOBLE aLPES | CHU Grenoble - Alpes | CHU Grenoble GOELAMS | CHU Grenoble - La Tronche | CHU of Grenoble | CIC, CHU Grenoble | GIPSA-LAB | Grenoble Alpes University Hospital, HP2 laboratory - INSERM U1042 and Grenoble Alpes University | Grenoble (FR), University College Hospital | Grenoble Hospital University | Groupe Hospitalier Mutualiste de Grenoble | Hopital Michalon , CHU de Grenoble | Hospital University Grenoble | INSERM + University Hospital Grenoble | Internal Medicine - University Hospital Grenoble-Alpes | Medical University of Grenoble | Nephrology Dialysis Transplantation/ CHU GRENOBLE | Pneumology Department, University Hospital of Grenoble | University Grenoble Alps | University Grenoble Hospital | University Hospital Grenoble | University Hospital, Grenoble | University Hospital Grenoble-Alpes | University Hospital, Grenoble Alpes, FRANCE | University Hospital of Genoble | University Hospital of Grenoble | University Hospital of Grenoble, France